SPX4,210.24+87.77 2.13%
DIA333.20+5.29 1.61%
IXIC12,854.81+360.88 2.89%

BRIEF-Pfizer Reports Q2 EPS Of $1.73

BRIEF-Pfizer Reports Q2 EPS Of $1.73

Reuters · 07/28/2022 06:50
BRIEF-Pfizer Reports Q2 EPS Of $1.73

- Pfizer Inc PFE:

  • PFIZER REPORTS SECOND-QUARTER 2022 RESULTS

  • Q2 EARNINGS PER SHARE $1.73

  • SECOND-QUARTER 2022 REVENUES OF $27.7 BILLION, REFLECTING 53% OPERATIONAL GROWTH

  • RAISES FULL-YEAR 2022 FINANCIAL GUIDANCE FOR REVENUES AND ADJUSTED DILUTED EPS(3) BY $2 BILLION AND $0.24, RESPECTIVELY

  • SECOND-QUARTER 2022 ADJUSTED DILUTED EPS OF $2.04

  • INCLUDING FOREIGN EXCHANGE IMPACTS, PFIZER REAFFIRMS 2022 REVENUE GUIDANCE OF $98.0 TO $102.0 BILLION

  • RAISES LOWER END OF 2022 ADJUSTED DILUTED EPS GUIDANCE BY $0.05 TO A RANGE OF $6.30 TO $6.45

  • CURRENT FINANCIAL GUIDANCE DOES NOT ANTICIPATE ANY ADDITIONAL SHARE REPURCHASES IN 2022

  • SEES 2022 REVENUES $98.0 BILLION TO $102.0 BILLION

  • SEES 2022 ADJUSTED DILUTED EPS $6.30 TO $6.45

  • PAXLOVID CONTRIBUTED $8.1 BILLION IN GLOBAL SALES IN QUARTER

  • QTRLY COMIRNATY SALES GLOBALLY, UP 20% OPERATIONALLY

  • Q2 EARNINGS PER SHARE VIEW $1.78, REVENUE VIEW $25.74 BILLION -- REFINITIV IBES DATA

  • REAFFIRMS 2022 REVENUE GUIDANCE FOR COMIRNATY AND PAXLOVID OF ABOUT $32 BILLION AND ABOUT $22 BILLION, RESPECTIVELY

  • FY2022 EARNINGS PER SHARE VIEW $6.59, REVENUE VIEW $102.92 BILLION -- REFINITIV IBES DATA

Source text for Eikon: ID:

Further company coverage: PFE


((Reuters.Briefs@thomsonreuters.com;))